Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Lerut

Showing results (71-80 of 192) with videos related to

Pageof 20
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2005
Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor poolDino Donataccio, Francine Roggen, Chantal De Reyck, et al.
World Journal of Hepatology|September 19, 2014
From portal to splanchnic venous thrombosis: What surgeons should bear in mindQuirino Lai, Gabriele Spoletini, Rafael S Pinheiro, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2010
Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?Krzysztof Mucha, Bartosz Foroncewicz, Bogna Ziarkiewicz-Wróblewska, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 16, 2011
Energy drinks: another red flag for the liver allograftCarlos A Apestegui, Olivier Julliard, Olga Ciccarelli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancerQuirino Lai, Edward Castro Santa, Juan M Rico Juri, et al.
Transplantation|November 19, 2004
Hematochezia and congenital extrahepatic portocaval shunt with absent portal vein: successful treatment by liver transplantationLionel Charre, Francine Roggen, Julien Lemaire, et al.
Clinical Transplantation|September 17, 2013
How much immunosuppression is needed after liver transplantation?Manuel Rodríguez-Perálvarez, Penelopi Manousou, Jan Lerut, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 9, 2020
SARS-CoV2 and immunosuppression: A double-edged swordQuirino Lai, Gabriele Spoletini, Giuseppe Bianco, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 31, 2006
Long-term survival after isolated liver transplantation for intrahepatic biliary papillomatosisLionel Charre, Olivier Boillot, Pierre Goffette, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2020
What did the European Liver Transplant Registry bring to liver transplantation?Jan Lerut, Vincent Karam, Valérie Cailliez, et al.
Pageof 20

Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2005
Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor poolDino Donataccio, Francine Roggen, Chantal De Reyck, et al.
World Journal of Hepatology|September 19, 2014
From portal to splanchnic venous thrombosis: What surgeons should bear in mindQuirino Lai, Gabriele Spoletini, Rafael S Pinheiro, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2010
Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?Krzysztof Mucha, Bartosz Foroncewicz, Bogna Ziarkiewicz-Wróblewska, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 16, 2011
Energy drinks: another red flag for the liver allograftCarlos A Apestegui, Olivier Julliard, Olga Ciccarelli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancerQuirino Lai, Edward Castro Santa, Juan M Rico Juri, et al.
Transplantation|November 19, 2004
Hematochezia and congenital extrahepatic portocaval shunt with absent portal vein: successful treatment by liver transplantationLionel Charre, Francine Roggen, Julien Lemaire, et al.
Clinical Transplantation|September 17, 2013
How much immunosuppression is needed after liver transplantation?Manuel Rodríguez-Perálvarez, Penelopi Manousou, Jan Lerut, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 9, 2020
SARS-CoV2 and immunosuppression: A double-edged swordQuirino Lai, Gabriele Spoletini, Giuseppe Bianco, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 31, 2006
Long-term survival after isolated liver transplantation for intrahepatic biliary papillomatosisLionel Charre, Olivier Boillot, Pierre Goffette, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2020
What did the European Liver Transplant Registry bring to liver transplantation?Jan Lerut, Vincent Karam, Valérie Cailliez, et al.
Pageof 20